Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL)

被引：1
|
作者：
Li, He [1 ]
Zhang, Wanhua [1 ]
Yi, Dongni [1 ]
Ye, Yuanxin [2 ]
Xiao, Xueqiu [3 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Hematol Res Lab, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 04期
关键词：
CHRONIC MYELOID-LEUKEMIA; BCR-ABL; CLINICAL IMPACT; IMATINIB; RESISTANT; THERAPY;
D O I：
10.1080/10428194.2016.1225205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1007
页数：3
相关论文
共 50 条
  • [31] Outcomes with inotuzumab ozogamicin (InO) in patients with Philadelphia chromosome-positive (Ph plus ) relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).
    Stock, Wendy
    Martinelli, Giovanni
    Stelljes, Matthias
    DeAngelo, Daniel J.
    Gokbuget, Nicola
    Advani, Anjali S.
    O'Brien, Susan Mary
    Liedtke, Michaela
    Merchant, Akil Abid
    Cassaday, Ryan Daniel
    Wang, Tao
    Vandendries, Erik
    Marks, David I.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Nilotinib in patients (pts) with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL) who are resistant or intolerant to imatinib
    Ottmann, Oliver G.
    Larson, Richard A.
    Kantarjian, Hagop M.
    le Coutre, Philipp
    Baccarani, Michele
    Haque, Ariful
    Gallagher, Neil
    Giles, Francis
    BLOOD, 2007, 110 (11) : 828A - 828A
  • [33] Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia
    Konoplev, Sergej
    Yin, C. Cameron
    Kornblau, Steven M.
    Kantarjian, Hagop M.
    Konopleva, Marina
    Andreeff, Michael
    Lu, Gary
    Zuo, Zhuang
    Luthra, Rajyalakshmi
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos E.
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 138 - 144
  • [34] Ponatinib use in two pediatric patients with relapsed Ph plus ALL with ABL1 kinase domain mutations
    Gruner, Stephanie E.
    Sayeed, Hadi
    Suarez-Ferguson, Lizmery
    Perez, Cintia
    Rouce, Rayne
    Fisher, Kevin E.
    Rau, Rachel E.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (08) : 514 - 519
  • [35] Outcome of Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) with Relapse After Tyrosine Kinase Inhibitor (TKI) Therapy
    Lee, Hun Ju
    O'Brien, Susan
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Faderl, Stefan
    Koller, Charles
    Konopleva, Marina
    Verstovsek, Srdan
    Kadia, Tapan
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Wierda, William G.
    Burger, Jan A.
    Thomas, Deborah A.
    Cortes, Jorge E.
    BLOOD, 2011, 118 (21) : 659 - 659
  • [36] Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
    Pfeifer, Heike
    Wassmann, Barbara
    Pavlova, Anna
    Wunderle, Lydia
    Oldenburg, Johannes
    Binckebanck, Anja
    Lange, Thoralf
    Hochhaus, Andreas
    Wystub, Silvia
    Brueck, Patrick
    Hoelzer, Dieter
    Ottmann, Oliver G.
    BLOOD, 2007, 110 (02) : 727 - 734
  • [37] THE TRANSLOCATION BREAKPOINT IN PHILADELPHIA CHROMOSOME-POSITIVE (PH1+) ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IS LINKED TO BCR
    WESTBROOK, CA
    RUBIN, CM
    HOOBERMAN, AL
    GEIGER, TA
    ROWLEY, JD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 200 - 200
  • [38] A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Matloub, Yousif
    Gore, Lia
    Loh, Mignon L.
    Pui, Chin-Hon
    Hanley, Michael J.
    Lu, Vickie
    Leonard, E. Jane
    Granier, Muriel
    Biondi, Andrea
    Silverman, Lewis B.
    BLOOD, 2020, 136
  • [39] Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Leonard, Jessica T.
    Rowley, Joelle S. J.
    Eide, Christopher A.
    Traer, Elie
    Hayes-Lattin, Brandon
    Loriaux, Marc
    Spurgeon, Stephen E.
    Druker, Brian J.
    Tyner, Jeffrey W.
    Chang, Bill H.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (354)
  • [40] BCR-ABL ONCOGENE ACTIVATION IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    HERMANS, A
    GOW, J
    SELLERI, L
    VONLINDERN, M
    HAGEMEIJER, A
    WIEDEMANN, LM
    GROSVELD, G
    LEUKEMIA, 1988, 2 (10) : 628 - 633
12345